CD19 and type 1 diabetes mellitus: We also observed no differences in the frequency of CD19+CD27−CD24hiCD38hi B cells between T1D patients and healthy controls, suggesting that there are no detectable B cell immunoregulatory alterations in peripheral blood of T1D patients after disease diagnosis.